- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $485.84M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $486.71M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $5M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $5M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $300.98M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $448.35M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $103.38M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $123.9M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $640.92M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $663.41M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $540.21M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $659.26M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.3B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.39B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 390.05M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $153.23M |
| Capex | Q1 2025 · Mar 31, 2024 | $407K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $42.59M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $631.07M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $761.96M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $41.11M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $31.02M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.01M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $7.38M |
| Revenue | Q1 2025 · Mar 31, 2024 | $197.88M |